Wells Fargo lowered the firm’s price target on Omnicell (OMCL) to $38 from $40 and keeps an Equal Weight rating on the shares. The firm is lowering its full-year revenue/EBITDA estimates to low end of guidance range, as Wells is mindful of downstream tariff impacts on equipment costs and exposure to international revenue. The firm believes Q1 was probably spared, with a beat still on the table.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue